Klaus Breiner

Investment Partner

Overview

Gender
male
Investor Type
Investment Partner

Klaus is a founding partner of Pureos and has been a venture capital investor since 2001, across different regions, companies stages and types. Prior to Pureos, he was senior investment advisor private equity at Bellevue Asset Management. Bio-pharmaceutical companies that Klaus has invested in include AM-Pharma, Alpex Pharma, Cadence Pharmaceuticals, Glycart Biotechnology, Hummingbird Bioscience, ImCheck Therapeutics and Vaximm. Before venture capital, Klaus was a researcher at ETH Zurich and a business consultant at Booz Allen & Hamilton. Klaus holds an MA in chemistry from the University of North Carolina, Chapel Hill, and a PhD in molecular biology from the University of Heidelberg (ZMBH).

Jobs

Number of Current Jobs
1
Klaus Breiner has 1 current jobs including Board Member at Tridek-One , .
Organization Name Title At Company Start Date End Date
Tridek-One Board Member Sep 1, 2022 Detail